Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Horizon Discovery Group PLC    HZD   GB00BK8FL363

HORIZON DISCOVERY GROUP PLC (HZD)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
10/09/2018 10/10/2018 10/11/2018 10/12/2018 10/15/2018 Date
212(c) 202(c) 212(c) 209(c) 200 Last
30 032 46 351 2 224 795 23 750 4 029 581 Volume
0.00% -4.72% +4.95% -1.42% -4.31% Change
More quotes
Financials (GBP)
Sales 2018 60,4 M
EBIT 2018 -5,50 M
Net income 2018 -6,73 M
Finance 2018 20,8 M
Yield 2018 -
Sales 2019 67,9 M
EBIT 2019 -1,28 M
Net income 2019 -2,74 M
Finance 2019 19,3 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 4,84x
EV / Sales2019 4,33x
Capitalization 313 M
More Financials
Company
Horizon Discovery Group Plc is a gene editing company, which engages in the design and engineering of genetically-modified cells.The firm operates through the following business segments: Products, Services, and Leveraged Research and Development.The Products segment sells cell lines and other... 
More about the company
Surperformance© ratings of Horizon Discovery Group PL
Trading Rating : Investor Rating :
More Ratings
Latest news on HORIZON DISCOVERY GROUP PL
10/05CELYAD : Announces Exclusive Agreement for Horizon Discoverys shRNA Platform to ..
AQ
10/04HORIZON DISCOVERY : enters into license agreement with Cytovance Biologics for H..
AQ
10/04CELYAD : - Celyad : Announces Exclusive Agreement for Horizon Discovery's shRNA ..
AQ
09/24HORIZON DISCOVERY : introduces Myeloid DNA Reference Standard to support genetic..
PU
09/17HORIZON DISCOVERY : Activist ValueAct raises stake in Horizon Discovery
RE
09/17HORIZON DISCOVERY GROUP PLC : Interim Results for the Six Months Ended 30 June 2..
GL
09/17HORIZON DISCOVERY : Interim Results for Six Months Ended 30 June 2018
PU
09/14HORIZON DISCOVERY : Edit-R crRNA Libraries Adopted by AstraZeneca as Part of its..
BU
09/12HORIZON DISCOVERY GROUP PLC : half-yearly earnings release
09/04HORIZON DISCOVERY : Holdings in Company
PU
More news
Sector news : Biotechnology & Medical Research - NEC
10/11GILEAD SCIENCES : Allogene's Upsized IPO Prices at High End of Range
DJ
10/05ABBVIE : Receives Health Canada Approval of Orilissa for Endometriosis Pain Trea..
DJ
10/04J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion
RE
10/02GILEAD SCIENCES : Allogene Sets IPO at 16 Million Shares; Sees Pricing $16-$18
DJ
09/28FDA Approves Libtayo to Treat Advanced Cutaneous Squamous Cell Carcinoma
DJ
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
10/04Celyad $CYAD Announces Exclusive Agreement for Horizon Discovery’s shRNA Plat.. 
10/04Celyad announces exclusive agreement for Horizon Discovery’s shRNA platform  
10/04Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform t.. 
10/04Celyad : accord exclusif avec Horizon Discovery Group plc  
10/03Horizon Discovery enters into license agreement with Cytovance Biologics for .. 
More tweets
Qtime:16
News from SeekingAlpha
10/04Celyad announces exclusive agreement for Horizon Discovery?s shRNA platform 
Chart HORIZON DISCOVERY GROUP PLC
Duration : Period :
Horizon Discovery Group PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HORIZON DISCOVERY GROUP PL
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 2,36  GBP
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Terrence William Pizzie Chief Executive Officer & Executive Director
Ian David Gilham Executive Chairman
Kim Nichols Head-Global Operations
Richard John Vellacott CFO, Secretary & Executive Director
Jonathan D. Moore Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
HORIZON DISCOVERY GROUP PLC-12.92%412
CELLTRION, INC.--.--%30 463
IQVIA HOLDINGS INC27.47%24 833
LONZA GROUP18.72%23 465
INCYTE CORPORATION-33.95%13 127
SEATTLE GENETICS, INC.36.02%11 255